Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Vaccine in Healthy Subjects
Clinical trial NCT02370589 · COMPLETED
Trial details
- NCT number
- NCT02370589
- Sponsor
- Novavax
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2016-04-01
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.